» Articles » PMID: 26252855

The Rationale for Transanal Total Mesorectal Excision

Overview
Specialty Gastroenterology
Date 2015 Aug 8
PMID 26252855
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Comparative efficacy analysis of laparoscopic-assisted transanal total mesorectal excision laparoscopic transanal mesorectal excision for low-lying rectal cancer.

Lu F, Tan S, Zuo J, Jiang H, Wang J, Jiang Y World J Gastrointest Surg. 2025; 17(1):100364.

PMID: 39872764 PMC: 11757205. DOI: 10.4240/wjgs.v17.i1.100364.


Transanal total mesorectal excision (TaTME) in rectal cancer treatment within an expert center.

Piatkowski J, Jagielski M, Szeliga J, Nowak M, Jackowski M Sci Rep. 2023; 13(1):17084.

PMID: 37816858 PMC: 10564843. DOI: 10.1038/s41598-023-44247-8.


Total mesorectal excision laparoscopic versus transanal approach for rectal cancer: A systematic review and meta-analysis.

Lo Bianco S, Lanzafame K, Piazza C, Piazza V, Provenzano D, Piazza D Ann Med Surg (Lond). 2022; 74:103260.

PMID: 35145658 PMC: 8802044. DOI: 10.1016/j.amsu.2022.103260.


Development and validation of a transanal endoscopic rectal purse string simulator.

Chau J, Bilgic E, Hada T, Trepanier M, Naghawi H, Kaneva P Tech Coloproctol. 2020; 24(8):863-871.

PMID: 32504373 DOI: 10.1007/s10151-020-02251-4.


Transanal Total Mesorectal Excision for Treatment of Carcinoma in the Middle or Lower Third Rectum: the Technical Feasibility of the Procedure, Pathological Results, and Clinical Outcome.

Abdelkader A, Zidan A, Younis M, Dawa S Indian J Surg Oncol. 2018; 9(4):442-451.

PMID: 30538370 PMC: 6265180. DOI: 10.1007/s13193-018-0808-9.